|View printer-friendly version|
|Array CEO Robert E. Conway to Speak at the UBS Warburg Global Life Sciences Conference|
BOULDER, Colo., Sept. 9 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the UBS Warburg Global Life Sciences Conference on September 25 in New York City. The public is welcome to listen to the presentation through an audio webcast on the UBS website.
To access the audio webcast, go to www.ibb.ubs.com and click on the conferences link found in the middle of the page. Follow the link for webcast under the Global Life Sciences Conference heading. The presentation will be available live and by replay. The replay of the presentation will begin three hours after the actual presentation time and will be available until October 25, 2003.
About Array BioPharma:
Array BioPharma is a drug discovery company creating new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists utilize a comprehensive set of drug discovery technologies, which we call the Array Discovery Platform(R), to invent drugs in collaboration with leading pharmaceutical and biotechnology companies and for our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com .
SOURCE Array BioPharma